Low-dose naltrexone / working resource

Clinical conversation planner

Bring specific questions and a source record to a qualified clinician.

Start with the product-specific question

What off-label means

Low-dose naltrexone, an off-label use, with the evidence and its limits in plain view. What should I know about what off-label use means?

A randomised, double-blind, placebo-controlled trial of 6 mg low-dose naltrexone in 99 women with fibromyalgia concluded that the study did not show treatment with low-dose naltrexone was superior to placebo in relieving pain.
Read the original record ↗

Open the Low-dose naltrexone library ↗

Choose the questions that need an answer.

Use the Low-dose naltrexone research to prepare a conversation, then let the clinician assess your individual situation. This worksheet does not determine eligibility or treatment.

What should I know about what off-label use means?What should I know about opioids and naltrexone?What should I know about compounded and approved naltrexone?Which evidence applies to the exact Low-dose naltrexone formulation being considered?What alternatives address the same goal, and what evidence supports them?Which risks, interactions and uncertainties matter for this decision?What would count as a useful outcome, and when would it be reassessed?Who should I contact if I have a problem or an unresolved question?The specific goal or uncertainty I want to discuss

Your conversation agenda

Select questions above to create your agenda here.

Source URLs and product documents to bringAnswers, unresolved points and agreed follow-up

Share personal health details only through your care provider's appropriate private channel. This page does not send or save your notes.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗